Clinical trial
The Japan Working Group for the Assessment That the Alpha-glucosidase Inhibitor Blocks Cardiac Events in Patients With Myocardial Infarction and IGT
NCT00212017 is registered in ClinicalTrials.gov with National Cerebral and Cardiovascular Center, Japan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Japan Working Group for the Assessment That the Alpha-glucosidase Inhibitor Blocks Cardiac Events in Patients With Myocardial Infarction and IGT
- Lead sponsor
- National Cerebral and Cardiovascular Center, Japan
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 30, 2005
- Completion date
- August 31, 2017
- Enrollment
- 3,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
impaired glucose tolerance, myocardial infarction